Non-immunologic intervention in chronic allograft nephropathy

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Volume 54, Pages S135-S139 (December 1998)

Volume 78, Issue 8, Pages (October 2010)

Volume 54, Issue 2, Pages (August 1998)

Beta blockers in the management of chronic kidney disease

Volume 67, Pages S1-S7 (June 2005)

Renal manifestations in Fabry disease and therapeutic options

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Epidemiology of diabetic nephropathy in Spain

Volume 68, Pages S52-S56 (December 2005)

Volume 78, Issue 8, Pages (October 2010)

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Volume 57, Issue 5, Pages (May 2000)

Burden of chronic kidney disease: North Africa

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

Volume 66, Pages S13-S17 (September 2004)

Infection and chronic allograft dysfunction

Volume 58, Issue 5, Pages (November 2000)

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Volume 74, Issue 3, Pages (August 2008)

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

Volume 70, Issue 11, Pages (December 2006)

Fernando Valderrábano, Francisco Gómez-Campderá, Elizabeth H.P. Jones

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

Prevention of renal failure: The Malaysian experience

Saulo Klahr, Jeremiah J. Morrissey Kidney International

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Volume 68, Pages S4-S10 (August 2005)

Changes in the number of circulating TCM and TEM subsets in renal transplantation: relationship with acute rejection and induction therapy David S. Segundo,

Volume 76, Issue 6, Pages (September 2009)

Volume 56, Pages S31-S37 (December 1999)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Methods for guideline development

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

Counteracting progression of renal disease: A look into the future

The global challenge of chronic kidney disease

Keng-Thye Woo, Yeow-Kok Lau, Kok-Seng Wong, Gilbert Shih-Chen Chiang

Measurement of renal function in pre-ESRD patients

Volume 54, Pages S135-S139 (December 1998)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 63, Issue 2, Pages (February 2003)

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Return to dialysis after renal transplantation

Volume 72, Issue 2, Pages (July 2007)

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Volume 80, Issue 10, Pages (November 2011)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Membranous nephropathy: recent travels and new roads ahead

Volume 54, Issue 6, Pages (January 1998)

The International Pediatric Peritonitis Registry: Starting to walk

Renal vascular disease in the elderly

Volume 54, Pages S112-S119 (December 1998)

Volume 57, Pages S44-S48 (April 2000)

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases Martina Franz, Wolfgang Woloszczuk,

Presentation transcript:

Non-immunologic intervention in chronic allograft nephropathy Manuel Arias, Gema Fernández-Fresnedo, Emilio Rodrigo, Juan Jarlos Ruiz, Julio González-Cotorruelo, Carlos Gómez-Alamillo Kidney International Volume 68, Pages S118-S123 (December 2005) DOI: 10.1111/j.1523-1755.2005.09922.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Progression of kidney disease expressed as serum creatinine in patients with good initial renal function (serum creatinine <1.5 mg/dL, left) and moderate renal insufficiency (serum creatinine 1.5–3 mg/dL, right) compared with those with (discontinuous line) and without (continuous line) proteinuria.*P < 0.01 for serum creatinine. Differences between proteinuria were significant for all points analyzed. Kidney International 2005 68, S118-S123DOI: (10.1111/j.1523-1755.2005.09922.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Progression of kidney disease expressed as serum creatinine in patients with good initial renal function (serum creatinine <1.5 mg/dL, left) and moderate renal insufficiency (serum creatinine 1.5–3 mg/dL, right) compared with those with (squares) and without (triangles) hypertension.*P < 0.01 for serum creatinine. Kidney International 2005 68, S118-S123DOI: (10.1111/j.1523-1755.2005.09922.x) Copyright © 2005 International Society of Nephrology Terms and Conditions